The company
PDS Biotechnology Corporation
PDSB · Nasdaq
PDSB stood above a rising 150-day average in 9 of the last 52 weekly readings, including each of the last 2 weeks. It is 11.0% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 50 (+12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,699,315$1.5M | +68,226+4.2% |
| Focus Partners Wealthnew · filed 12 Aug 2026 | 642,177$566K | +642,177 |
| Quantinno Capital Management LPnew · filed 13 Aug 2026 | 642,177$566K | +642,177 |
| BlackRock, Inc.added · filed 7 Aug 2026 | 607,639$535K | +53,591+9.7% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 587,139$517K | -73,089−11.1% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 357,144$315K | +49,833+16.2% |
| Militia Capital Management LLCnew · filed 12 Aug 2026 | 331,800$292K | +331,800 |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 323,801$285K | +323,801 |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 313,922$277K | +310,000+7904.1% |
| BLAIR WILLIAM & COunchanged · filed 11 Aug 2026 | 300,000$264K | 00.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.